Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A

Antimicrob Agents Chemother. 2009 Feb;53(2):496-504. doi: 10.1128/AAC.00633-08. Epub 2008 Dec 1.

Abstract

By using a detergent-washed membrane preparation, the interaction of the fungal natural product inhibitor aureobasidin A (AbA) with inositol phosphorylceramide synthase (IPC synthase) was studied by kinetic analysis of wild-type and mutant enzyme-catalyzed reactions. AbA inhibited the wild-type enzyme from both Candida albicans and Saccharomyces cerevisiae in an irreversible, time-dependent manner, with apparent K(i) values of 183 and 234 pM, respectively. Three synthetic chemistry-derived AbA derivatives, PHA-533179, PHA-556655, and PHA-556656, had affinities 4 to 5 orders of magnitude lower and were reversible inhibitors that competed with the donor substrate phosphatidylinositol (PI). AbA was a reversible, apparently noncompetitive inhibitor, with a K(i) of 1.4 microM, of the IPC synthase from an AbA-resistant S. cerevisiae mutant. The K(m) values for both substrates (ceramide and PI) were similar when they interacted with the mutant and the wild-type enzymes. By contrast, the V(max) for the mutant enzyme was less than 10% of that for the wild-type enzyme. A comparison of the results obtained with AbA with those obtained with two other natural products inhibitors, rustmicin and khafrefungin, revealed that while rustmicin appeared to be a reversible, noncompetitive inhibitor of the wild-type enzyme, with a K(i) of 16.0 nM, khafrefungin had the kinetic properties of a time-dependent inhibitor and an apparent K(i) of 0.43 nM. An evaluation of the efficiencies of these compounds as inhibitors of the mutant enzyme revealed for both a drop in the apparent affinity for the enzyme of more than 2 orders of magnitude.

MeSH terms

  • Algorithms
  • Antifungal Agents / pharmacology*
  • Candida albicans / drug effects
  • Depsipeptides / pharmacology*
  • Drug Resistance, Fungal
  • Enzyme Inhibitors / pharmacology*
  • Glycolipids / pharmacology
  • Hexosyltransferases / antagonists & inhibitors*
  • Kinetics
  • Saccharomyces cerevisiae / drug effects
  • Time Factors

Substances

  • Antifungal Agents
  • Depsipeptides
  • Enzyme Inhibitors
  • Glycolipids
  • khafrefungin
  • aureobasidin A
  • Hexosyltransferases
  • phosphatidylinositol-ceramide phosphoinositol transferase